化学因子受体概况作为卵泡淋巴瘤生存和早期进展的预测因素
Antonella Zupo1, Katrin Pansy1, Lukas Gaksch1
1Division of Hematology Medical University of Graz Graz Austria.
EJHaem
|September 2, 2025
概括
毛囊性淋巴瘤 (FL) 中的化学激素受体 (CR) 表达特征可以预测疾病的进展. 像CCR3,CCR4和CCR10这样的CR升高与生存率低下有关,为早期进展病例提供潜在的治疗点.
科学领域:
- 血液学
- 癌症学
- 免疫学
背景情况:
- 古典毛囊性淋巴瘤 (FL) 是一种异质的B细胞恶性瘤,临床结果各不相同.
- 在24个月内早期进展 (POD24) 预示着预后不佳,需要改进风险分层方法.
研究的目的:
- 调查FL中的化学激素受体 (CR) 表达特征.
- 确定疾病生物学和患者结果的潜在CR生物标志物,特别是POD24.
主要方法:
- 使用RT-qPCR对52个FL样本 (13个POD24,39个非POD24) 的mRNA表达的分析.
- 对所选CR进行免疫组织化学检查 (CCR3,CCR7,CXCR3,CXCR4,CXCR5).
- 与反应性桃体组织作为对照进行比较.
主要成果:
- 与对照组相比,FL样本表现出明显的CR表达,多个CR的水平发生了变化.
- 3a级FL显示了特定的CR表达模式 (例如,减少了CCR8,增加了CCR7).
- 在POD24病例中,高CCR3,高CCR4,高CCR7,高CCR4,高CCR1和低CXCR3呈现出较低的生存率.
结论:
- 不同的CR表达特征与FL进展和临床结果有关.
- 特定的CRs (CCR3,CCR4,CCR10,CXCR3) 成为FL的潜在预后标志物,特别是POD24.
- 这些CR代表了改善高风险FL患者治疗结果的潜在治疗目标.
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...